FIELD: biotechnology, in particular utilization of strain Lactobacillus salivarius UCC 118 for prophylaxis and/or treatment of undesired inflammation activity and cancer prophylaxis.
SUBSTANCE: human-original strain Lactobacillus salivarius UCC 118[NCIMB 40829] is isolated from dissected and washed human gastrointestinal tract. Strain application makes it possible to decelerate development of malignant diseases and to reduce undesired inflammation activity such as intestine inflammation or irritable colon.
EFFECT: strain for prophylaxis and/or treatment of undesired inflammation activity and cancer prophylaxis.
42 cl, 29 dwg, 1 tbl, 4 ex
Authors
Dates
2006-07-10—Published
2000-01-17—Filed